PMN logo

ProMIS Neurosciences (PMN) Shareholders Equity

Annual Shareholders Equity

$3.75 M
+$5.10 M+378.48%

December 31, 2023


Summary


Performance

PMN Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPMNbalance sheetmetrics:

Quarterly Shareholders Equity

$7.27 M
+$9.55 M+419.41%

September 30, 2024


Summary


Performance

PMN Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPMNbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

PMN Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+378.5%+7.7%
3 y3 years+571.1%+896.6%
5 y5 years+342.1%+205.7%

PMN Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-33.7%+378.5%at high+185.3%
5 y5-year-33.7%+378.5%-3.6%+185.3%
alltimeall time-69.2%+378.5%-40.4%+185.3%

ProMIS Neurosciences Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$7.27 M(-419.4%)
Jun 2024
-
-$2.28 M(-3053.4%)
Mar 2024
-
$77.10 K(-97.9%)
Dec 2023
$3.75 M(-378.5%)
$3.75 M(-44.4%)
Sep 2023
-
$6.75 M(-179.2%)
Jun 2023
-
-$8.53 M(+38.0%)
Mar 2023
-
-$6.18 M(+358.5%)
Dec 2022
-$1.35 M(-123.8%)
-$1.35 M(-284.7%)
Sep 2022
-
$729.80 K(-89.1%)
Jun 2022
-
$6.71 M(+79.5%)
Mar 2022
-
$3.74 M(-33.9%)
Dec 2021
$5.66 M(-810.4%)
$5.66 M(-25.0%)
Sep 2021
-
$7.54 M(-206.3%)
Jun 2021
-
-$7.10 M(+3.2%)
Mar 2021
-
-$6.88 M(+763.5%)
Dec 2020
-$796.70 K(-361.4%)
-$796.70 K(-47.8%)
Sep 2020
-
-$1.53 M(+293.1%)
Jun 2020
-
-$388.10 K(+184.1%)
Mar 2020
-
-$136.60 K(-144.8%)
Dec 2019
$304.80 K(-64.1%)
-
Dec 2019
-
$304.80 K(-142.0%)
Sep 2019
-
-$725.10 K(-274.7%)
Jun 2019
-
$415.10 K(-52.1%)
Mar 2019
-
$867.40 K(+2.2%)
Dec 2018
$848.90 K(-30.4%)
-
Dec 2018
-
$848.90 K(-75.3%)
Sep 2018
-
$3.44 M(-33.1%)
Jun 2018
-
$5.15 M(+258.8%)
Mar 2018
-
$1.43 M(+17.6%)
Dec 2017
$1.22 M(+2258.6%)
$1.22 M(-41.8%)
Sep 2017
-
$2.10 M(-3681.9%)
Jun 2017
-
-$58.50 K(-104.7%)
Mar 2017
-
$1.24 M(+2292.3%)
Dec 2016
$51.70 K(-88.0%)
$51.70 K(-93.8%)
Sep 2016
-
$833.30 K(+181.4%)
Jun 2016
-
$296.10 K(-38.6%)
Mar 2016
-
$482.30 K(+11.5%)
Dec 2015
$432.40 K(-353.2%)
$432.40 K(-47.1%)
Sep 2015
-
$817.90 K(-213.7%)
Jun 2015
-
-$719.50 K(+45.8%)
Mar 2015
-
-$493.50 K(+570.5%)
Dec 2014
-$170.80 K
-
Sep 2014
-
-$73.60 K(-118.3%)
DateAnnualQuarterly
Jun 2014
-
$402.70 K(+8654.3%)
Mar 2014
$4600.00(-102.2%)
$4600.00(-101.0%)
Dec 2013
-
-$483.40 K(+46.6%)
Sep 2013
-
-$329.80 K(-1199.3%)
Jun 2013
-
$30.00 K(-114.1%)
Mar 2013
-$212.50 K(-126.2%)
-$212.50 K(-237.9%)
Dec 2012
-
$154.10 K(-76.5%)
Sep 2012
-
$654.60 K(-44.5%)
Jun 2012
-
$1.18 M(+45.4%)
Mar 2012
$810.90 K(-67.2%)
$810.90 K(+18.8%)
Dec 2011
-
$682.80 K(-47.1%)
Sep 2011
-
$1.29 M(-34.3%)
Jun 2011
-
$1.96 M(-20.6%)
Mar 2011
$2.47 M(-47.1%)
$2.47 M(-5.9%)
Dec 2010
-
$2.63 M(-19.3%)
Sep 2010
-
$3.26 M(+7.6%)
Jun 2010
-
$3.02 M(-35.2%)
Mar 2010
$4.67 M(+19.9%)
$4.67 M(-14.3%)
Dec 2009
-
$5.45 M(-7.8%)
Sep 2009
-
$5.91 M(-2.7%)
Jun 2009
-
$6.07 M(+55.8%)
Mar 2009
$3.90 M(-53.9%)
$3.90 M(-19.0%)
Dec 2008
-
$4.81 M(-20.1%)
Sep 2008
-
$6.03 M(-16.0%)
Jun 2008
-
$7.18 M(-15.1%)
Mar 2008
$8.45 M(-30.7%)
$8.45 M(-19.2%)
Dec 2007
-
$10.45 M(-10.4%)
Sep 2007
-
$11.66 M(-3.9%)
Jun 2007
-
$12.13 M(-0.6%)
Mar 2007
$12.20 M(+168.3%)
$12.20 M(+135.1%)
Dec 2006
-
$5.19 M(-1.1%)
Sep 2006
-
$5.24 M(+9.6%)
Jun 2006
-
$4.78 M(+5.2%)
Mar 2006
$4.55 M
$4.55 M(+121.0%)
Dec 2005
-
$2.06 M(-12.0%)
Sep 2005
-
$2.34 M(+745.7%)
Jun 2005
-
$276.20 K(+145.5%)
Dec 2002
-
$112.50 K(-24.0%)
Jun 2002
-
$148.10 K(-303.2%)
Dec 2001
-
-$72.90 K(-417.0%)
Jun 2001
-
$23.00 K(-75.7%)
Dec 2000
-
$94.60 K(-79.1%)
Jun 2000
-
$452.70 K

FAQ

  • What is ProMIS Neurosciences annual stockholders equity?
  • What is the all time high annual shareholders equity for ProMIS Neurosciences?
  • What is ProMIS Neurosciences annual shareholders equity year-on-year change?
  • What is ProMIS Neurosciences quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ProMIS Neurosciences?
  • What is ProMIS Neurosciences quarterly shareholders equity year-on-year change?

What is ProMIS Neurosciences annual stockholders equity?

The current annual shareholders equity of PMN is $3.75 M

What is the all time high annual shareholders equity for ProMIS Neurosciences?

ProMIS Neurosciences all-time high annual stockholders equity is $12.20 M

What is ProMIS Neurosciences annual shareholders equity year-on-year change?

Over the past year, PMN annual stockholders equity has changed by +$5.10 M (+378.48%)

What is ProMIS Neurosciences quarterly stockholders equity?

The current quarterly shareholders equity of PMN is $7.27 M

What is the all time high quarterly shareholders equity for ProMIS Neurosciences?

ProMIS Neurosciences all-time high quarterly stockholders equity is $12.20 M

What is ProMIS Neurosciences quarterly shareholders equity year-on-year change?

Over the past year, PMN quarterly stockholders equity has changed by +$518.30 K (+7.67%)